84964-13-6

Basic information

• Product Name: (3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid
• Synonyms: Eburnamenine-14-carboxylic acid, 11-bromo-14,15-dihydro-14-hydroxy-, (3alpha,14beta,16alpha)-
• CAS NO: 84964-13-6
• Molecular Formula: C₂₀H₂₃BrN₂O₃
• Molecular Weight: 419.3122
• Mol File: 84964-13-6.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 616.4°C at 760 mmHg
• Flash Point: 326.6°C
• Density: 1.69g/cm³
• Vapor Pressure: 4.72E-16mmHg at 25°C
• Refractive Index: 1.749
• CAS DataBase Reference: (3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid(84964-13-6)
• EPA Substance Registry System: (3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid(84964-13-6)

Safety Data

• Hazardous Substances Data: 84964-13-6(Hazardous Substances Data)

Usage

Description

(3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid is a complex chemical compound that belongs to the class of eburnamine alkaloids. It is characterized by a bromine atom at position 11, a hydroxy group at position 14, and a carboxylic acid group at position 14. (3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid also contains a dihydroeburnamenine skeleton, which consists of a tetracyclic ring structure. This chemical compound has potential pharmacological properties and may be of interest for further study in the field of medicinal chemistry and drug discovery.

Uses

Used in Pharmaceutical Industry:
(3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid is used as a potential pharmaceutical candidate for the development of new drugs due to its unique chemical structure and potential pharmacological properties. Its tetracyclic ring system and functional groups may allow for the modulation of various biological targets and pathways, making it a promising candidate for the treatment of various diseases and conditions.
Used in Medicinal Chemistry Research:
(3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid is used as a subject of study in medicinal chemistry research to explore its potential as a lead compound for drug discovery. Its unique structure and functional groups can be further modified and optimized to enhance its pharmacological properties and therapeutic potential.
Used in Drug Synthesis:
(3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid can be used as a starting material or intermediate in the synthesis of other complex organic compounds and pharmaceuticals. Its unique structure and functional groups can be utilized in various chemical reactions to produce new compounds with potential therapeutic applications.
Used in Drug Delivery Systems:
(3alpha,14beta,16alpha)-11-bromo-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylic acid can be incorporated into drug delivery systems to improve the bioavailability, targeting, and therapeutic efficacy of other drugs. Its unique structure and functional groups can be used to design and develop novel drug delivery systems, such as nanoparticles, liposomes, or hydrogels, to enhance the delivery and performance of pharmaceuticals.